Home > Technical section > Biotechnology > Biotech companies > Rules-Based Medicine

Rules-Based Medicine

Friday 14 December 2007


Rules-Based Medicine (RBM) is a biomarker testing laboratory delivering reproducible, quantitative, multiplexed immunoassay data. RPM use Multi-Analyte Profiles (MAP’s) to measure up to hundreds of proteins in a very small sample in multiple species and sample types. MAPs provide a comprehensive and cost-effective evaluation of the protein expression patterns that are critical to applications such as drug safety and efficacy, disease diagnosis and disease modeling. RBM is CLIA certified and supports GLP studies.